diaDexus, Inc. (OTCQB:DDXS), a commercial stage developer of proprietary cardiovascular diagnostic products, today announced that Kenneth C. Fang, M.D. will join the company as chief medical officer. Dr. Fang brings more than 25 years of experience as a physician-scientist with substantial corporate experience in biomarker discovery and applications for diagnostic product development and commercialization in diverse indications, including cardiovascular disease and inflammation.
Help employers find you! Check out all the jobs and post your resume.
